Contract A236_P0348983

Virginia Commonwealth University awarded a contract to Addgene Inc on August 7, 2026, with a cumulative value of $282. The contract involves the delivery of three distinct plasmid or vector products, each with a unit price of $94. The line items include a green fluorescent protein (GFP) expression vector with an AAV (adeno-associated virus) backbone, a GFP-containing plasmid designated for high-throughput applications, and a minimal CAP (capsid) plasmid for PHP serotype production. All deliverables are directed to VCU Procurement, indicating Virginia Commonwealth University as the place of performance.

As a prime contractor, Addgene Inc is responsible for supplying these molecular biology research reagents to support Virginia Commonwealth University's research initiatives. The contract represents a modest procurement of standardized biological materials commonly utilized in academic research settings. No specific contract performance period is documented in the award materials provided.